PMID: 15247533Jul 13, 2004Paper

Dopamine dysregulation syndrome in Parkinson's disease

Current Opinion in Neurology
Andrew H Evans, Andrew Lees

Abstract

Dopamine replacement therapy in Parkinson's disease ameliorates motor symptoms. However, it has recently been recognized that a small sub-group of patients suffer motor and behavioural disturbances attributable to taking quantities of medication well beyond the dose required to treat their motor disabilities. This review examines the phenomenology of dopamine dysregulation syndrome in relation to the current understanding of basal ganglia function and its impact on long-term management. Cortico-striato-thalamic circuits are implicated in the behavioural and motor disturbances associated with compulsive medication use in Parkinson's disease. Advances in understanding of the role of dopamine in psychostimulant addiction are important in helping to understand dopamine dysregulation. Recognition of dopamine dysregulation syndrome and characterization of its phenomenology supports the notion that the medication used to treat Parkinson's disease can disrupt basal ganglia mediated motor and behavioural functioning. Refinement of clinical strategies to predict, identify and manage this syndrome will aid the future treatment of motor and non-motor complications of Parkinson's disease.

References

Feb 15, 1992·Biological Psychiatry·R G Ross, N G Ward
Oct 1, 1989·Annals of Neurology·D C GermanC B Saper
Sep 1, 1988·Acta Psychiatrica Scandinavica·E TackA Remouchamps
Jan 1, 1985·Clinical Neuropharmacology·P A Nausieda
Jul 1, 1984·Pharmacopsychiatry·S Priebe
Jul 1, 1983·Pharmacopsychiatria·H P Vogel, R Schiffter
Mar 1, 1983·The British Journal of Psychiatry : the Journal of Mental Science·N P QuinnJ D Parkes
Apr 1, 1997·Clinical Neuropharmacology·E CourtyJ Lavarenne
Mar 23, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·G GiovannoniA J Lees
Jul 29, 2000·The American Journal on Addictions·D Harris, S L Batki
Aug 11, 2001·Science·R de la Fuente-FernándezA J Stoessl
May 9, 2002·Neuroreport·Andrew D LawrencePaul M Grasby
Jul 26, 2002·Nature·Johan LauwereynsOkihide Hikosaka
Aug 15, 2002·Neurology·Tatiana WitjasA Ali Chérif
Aug 20, 2002·Annual Review of Psychology·Terry E Robinson, Kent C Berridge
Sep 7, 2002·Der Nervenarzt·U MüllerH J Gertz
Oct 18, 2002·Neuron·Wolfram Schultz
Nov 6, 2002·Neuropsychologia·V CzerneckiB Dubois
Nov 14, 2002·Behavioural Brain Research·Raúl de la Fuente-FernándezA Jon Stoessl
Dec 25, 2002·Neuroreport·Susanne ErkHenrik Walter
Feb 1, 2003·Neurobiology of Learning and Memory·T W Robbins, B J Everitt
Mar 4, 2003·Journal of Neurophysiology·Howard C Cromwell, Wolfram Schultz
Mar 22, 2003·Science·Christopher D FiorilloWolfram Schultz
Mar 26, 2003·Psychopharmacology·Peter W Kalivas, Krista McFarland
Apr 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Yilin LiTerry E Robinson
Apr 23, 2003·Der Nervenarzt·Ch BergerH-M Meinck
May 2, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Aurélie FunkiewiezPierre Pollak
May 6, 2003·Annals of Neurology·Paola PicciniDavid J Brooks
Aug 13, 2003·Archives of General Psychiatry·Marc N PotenzaBruce E Wexler
Sep 23, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Murat Emre
Nov 26, 2003·Neurology·Israel Steiner, Itzhak Wirguin
Apr 13, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Valerie Voon
Apr 13, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Andrew H EvansAndrew J Lees
Apr 13, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Roger Kurlan

❮ Previous
Next ❯

Citations

Apr 21, 2007·Current Treatment Options in Neurology·Wendy R Galpern, Mark Stacy
Sep 1, 2006·Journal of Neurology·David J Brooks
Dec 1, 2006·Wiener klinische Wochenschrift·David J Brooks
Dec 1, 2012·Journal of Neural Transmission·Dénes ZádoriLászló Vécsei
Dec 13, 2012·Journal of Neural Transmission·Nicola J Ray, Antonio P Strafella
Jan 27, 2009·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·F RaudinoG Bono
Jun 11, 2009·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Silvia CabriniMaurizio Avanzi
Nov 20, 2012·Journal of the International Neuropsychological Society : JINS·Lesley K Fellows
Sep 21, 2011·Molecular Psychiatry·J LuigjesD Denys
Nov 23, 2006·Antioxidants & Redox Signaling·Marat V AvshalumovMargaret E Rice
Mar 12, 2008·The Neurologist·William Stamey, Joseph Jankovic
May 7, 2010·The Neurologist·Gülay KenangilEthem Erginöz
Sep 18, 2008·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·David KnobelAlexandre Berney
Feb 23, 2012·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Katerina FarnikovaJan Prasko
Aug 7, 2012·Biochemistry. Biokhimii︠a︡·E V FilatovaP A Slominsky
Feb 10, 2011·The Journal of Neuropsychiatry and Clinical Neurosciences·Laura B ZahodneHubert H Fernandez
Mar 1, 2011·Therapeutic Advances in Chronic Disease·Steven Wishart, Graeme J A Macphee
Jan 5, 2007·BMC Neuroscience·Thomas LembergerGünther Schütz
Apr 5, 2013·Journal of Psychiatry & Neuroscience : JPN·Céline DelerueMuriel Boucart
Mar 15, 2013·Neuropsychiatric Disease and Treatment·David J Pedrosa, Lars Timmermann
Apr 11, 2008·CNS Drugs·Malcolm Lader
Dec 10, 2013·Annual Review of Clinical Psychology·B B AverbeckA Djamshidian
Apr 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Trinna L CuellarMichael T McManus
Sep 20, 2008·Journal of Neurology·Eric Ch WoltersOdile A van den Heuvel
Oct 21, 2009·Journal of Biomedicine & Biotechnology·Sabata MartinoAldo Orlacchio
Aug 28, 2012·Revue neurologique·T WitjasJ-P Azulay
Apr 3, 2012·World Neurosurgery·Judy LuigjesDamiaan Denys
Feb 18, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·P SollaF Marrosu
Mar 13, 2010·Parkinsonism & Related Disorders·Melis SohtaoğluEthem Erginöz
Aug 18, 2009·Revue neurologique·C ArdouinUNKNOWN groupe évaluation comportementale de la maladie de Parkinson
Jul 30, 2008·Current Opinion in Neurobiology·Natascha Bushati, Stephen M Cohen
Apr 29, 2008·Revue neurologique·M Borg, C Bayreuther
Nov 9, 2007·Parkinsonism & Related Disorders·Doron Merims, Nir Giladi
Sep 7, 2007·Journal of the Neurological Sciences·Daniel D TruongErik Wolters
Aug 19, 2007·Parkinsonism & Related Disorders·William G Ondo, Dejian Lai
Sep 2, 2015·Neurobiology of Disease·M Angela CenciHanna S Lindgren
Apr 25, 2006·Annals of Neurology·Antonello Bonci, Vineeta Singh
Oct 19, 2007·Acta Psychiatrica Scandinavica. Supplementum·M BerkT Norman
Mar 25, 2006·Annals of Neurology·Andrew H EvansPaola Piccini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Francesca Romana PezzellaGiuseppe Meco
Movement Disorders : Official Journal of the Movement Disorder Society
Tatiana WitjasJean Philippe Azulay
Movement Disorders : Official Journal of the Movement Disorder Society
Andrew H EvansAndrew Lees
Movement Disorders : Official Journal of the Movement Disorder Society
J A MolinaF Bermejo
© 2022 Meta ULC. All rights reserved